People: ACADIA Pharmaceuticals Inc (ACAD.O)

ACAD.O on Nasdaq

41.57USD
6 Jul 2015
Change (% chg)

$-0.12 (-0.29%)
Prev Close
$41.69
Open
$41.30
Day's High
$42.00
Day's Low
$40.77
Volume
750,694
Avg. Vol
1,197,704
52-wk High
$46.48
52-wk Low
$19.21

Search Stocks

Baity, Glenn 

Mr. Glenn F. Baity is Executive Vice President, General Counsel, Secretary of ACADIA Pharmaceuticals Inc. He was Vice President, General Counsel, Secretary of ACADIA Pharmaceuticals Inc. From February 2000 until joining us, Mr. Baity was a senior associate at Cooley LLP in their San Diego office, working with a variety of public and private companies on transactional matters, including M&A, financings, compensation and equity matters, and corporate governance. Prior to joining Cooley, Mr. Baity was an associate in the San Francisco office of Brown & Wood LLP (now Sidley Austin LLP) working primarily on public financings for established companies while representing bulge bracket underwriters, such as Goldman Sachs, Merrill Lynch and Morgan Stanley. Mr. Baity received a J.D. from the University of California, Los Angeles and received a B.A. from the University of California, Berkeley.

Basic Compensation

Total Annual Compensation, USD 457,000
Restricted Stock Awards, USD --
Long-Term Incentive Plans, USD --
All Other, USD 2,851,980
Fiscal Year Total, USD 3,308,980

Options Compensation

  Quantity Market Value
Exercisable -- --
Unexercisable -- --
Exercised 50,000 1,262,460.00
Name Fiscal Year Total

Leslie Iversen

--

Stephen Davis

5,208,920

Glenn Baity

3,308,980

Roger Mills

3,704,310

Terrence Moore

1,214,040

Stephen Biggar

--
As Of  30 Dec 2014
Search Stocks